TSRI Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology
Tuesday, January 10, 2017 - 13:31
in Mathematics & Economics
The Scripps Research Institute (TSRI), a leading non-profit biomedical research institute, today announced a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) to pioneer new DNA-encoded library (DEL) technology, including new synthetic chemistry for the creation of next-generation DELs, a potentially transformative technology for early stage drug discovery research.